相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements
Angel F. Remacha et al.
ANNALS OF HEMATOLOGY (2010)
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
Norbert Gattermann et al.
LEUKEMIA RESEARCH (2010)
Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes
Peter L. Greenberg et al.
LEUKEMIA RESEARCH (2010)
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines
V. Santini et al.
LEUKEMIA RESEARCH (2010)
Myelodysplastic Syndromes-Many New Drugs, Little Therapeutic Progress
Ayalew Tefferi
MAYO CLINIC PROCEEDINGS (2010)
Update on the use of deferasirox in the management of iron overload
Ali Taher
Therapeutics and Clinical Risk Management (2010)
Deferasirox (Exjade®) for the Treatment of Iron Overload
M. D. Cappellini et al.
ACTA HAEMATOLOGICA (2009)
Update on the therapy for myelodysplastic syndrome
Margaret T. Kasner et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?
Vinod Pullarkat
BLOOD (2009)
Iron chelation therapy in myelodysplastic syndrome - Cui bono?
A. Tefferi et al.
LEUKEMIA (2009)
Mechanisms of Disease: Myelodysplastic Syndromes.
Ayalew Tefferi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Consensus statement on iron overload in myelodysplastic syndromes
John M. Bennett
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes
Elias Jabbour et al.
CANCER (2008)
Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
Takahiro Suzuki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
Norbert Gattermann
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes
Luca Malcovati
LEUKEMIA RESEARCH (2007)
Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review
Thomas E. Delea et al.
TRANSFUSION (2007)
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
Luca Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia
MD Cappellini et al.
BLOOD (2006)
The myelodysplastic syndromes: Diagnosis and treatment
DP Steensma et al.
MAYO CLINIC PROCEEDINGS (2006)
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making
L Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Deferiprone therapy for transfusional iron overload
AV Hoffbrand
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2005)
Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone
AR Cohen et al.
BLOOD (2003)
Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool
PD Jensen et al.
BLOOD (2003)
Oxidative stress and the myelodysplastic syndromes
MJ Farquhar et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
D Bowen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients
A Ceci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Practical management of iron overload
JB Porter
BRITISH JOURNAL OF HAEMATOLOGY (2001)
A comparison of observational studies and randomized, controlled trials.
K Benson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Randomized, controlled trials, observational studies, and the hierarchy of research designs.
J Concato et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)